Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

The coronavirus disease 2019 (COVID-19) (caused by severe acute respiratory syndrome coronavirus 2) pandemic has massively distorted our health care systems and caused catastrophic consequences in our affected communities. The number of victims continues to increase, and patients at risk can only be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Allergy Clin Immunol
Hauptverfasser: Valent, Peter, Akin, Cem, Bonadonna, Patrizia, Brockow, Knut, Niedoszytko, Marek, Nedoszytko, Boguslaw, Butterfield, Joseph H., Alvarez-Twose, Ivan, Sotlar, Karl, Schwaab, Juliana, Jawhar, Mohamad, Reiter, Andreas, Castells, Mariana, Sperr, Wolfgang R., Kluin-Nelemans, Hanneke C., Hermine, Olivier, Gotlib, Jason, Zanotti, Roberta, Broesby-Olsen, Sigurd, Horny, Hans-Peter, Triggiani, Massimo, Siebenhaar, Frank, Orfao, Alberto, Metcalfe, Dean D., Arock, Michel, Hartmann, Karin
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297685/
https://ncbi.nlm.nih.gov/pubmed/32561389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.06.009
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge